Naltrexone is NOT a Scheduled or Controlled Substance in the United States
Naltrexone is unscheduled under the Controlled Substances Act, meaning any licensed physician can prescribe it without special DEA registration or restrictions 1. This stands in stark contrast to opioid agonists like methadone and buprenorphine, which require special waivers and are subject to controlled substance regulations.
Key Regulatory Status
Naltrexone's unscheduled status is explicitly documented in the medical literature and represents a significant advantage for prescribers and patients:
- No DEA scheduling: Unlike phentermine (Schedule IV) 2 or phentermine/topiramate (Schedule IV) 3, 2, naltrexone carries no controlled substance classification
- No prescribing restrictions: Any licensed physician can prescribe naltrexone without obtaining a waiver from SAMHSA, unlike buprenorphine which requires special certification 4
- Minimal abuse potential: As an opioid antagonist rather than agonist, naltrexone has "very limited potential for misuse or diversion" 5
Clinical Implications
This unscheduled status has important practical implications:
Prescribing flexibility: The lack of scheduling allows for decentralized therapeutic approaches, permitting patients to access treatment through any licensed physician rather than specialized addiction treatment programs 1. This is particularly valuable for patients seeking treatment for alcohol use disorder or opioid use disorder in primary care settings.
No special monitoring requirements: Unlike scheduled medications that require prescription drug monitoring program (PDMP) checks and special record-keeping, naltrexone can be prescribed like any other non-controlled medication.
Available formulations: Naltrexone is available as both oral tablets (Revia) and extended-release injectable (Vivitrol) 6, with neither formulation carrying controlled substance restrictions.
Important Distinction from Naloxone
While naltrexone is unscheduled, it should not be confused with naloxone (Narcan), which is also an opioid antagonist used for overdose reversal. Both are unscheduled, but serve different clinical purposes 6.
Contraindications and Cautions
Despite being unscheduled, naltrexone has important clinical contraindications:
- Cannot be used with concurrent opioid therapy: Naltrexone blocks opioid receptors and will precipitate withdrawal in opioid-dependent patients 3, 7
- Requires opioid-free period: Patients must be opioid-free for 7-10 days (short-acting opioids) or up to 2 weeks (buprenorphine/methadone) before initiating naltrexone 7
- Hepatic considerations: While historically there were concerns about hepatotoxicity, recent evidence shows naltrexone is safe even in patients with severe alcohol-associated cirrhosis 8
The unscheduled status of naltrexone removes a significant barrier to treatment access for patients with alcohol use disorder and opioid use disorder, allowing broader prescribing by general practitioners without the regulatory burden associated with controlled substances.